NO932044L - Funksjonaliserte, vinylazolholdige, farmasoeytiske preparater, anvendelse av disse vinylazoler for fremstilling av legemidler, vinylazoler i seg selv, saavel som fremgangsmaater for deres fremstilling - Google Patents

Funksjonaliserte, vinylazolholdige, farmasoeytiske preparater, anvendelse av disse vinylazoler for fremstilling av legemidler, vinylazoler i seg selv, saavel som fremgangsmaater for deres fremstilling

Info

Publication number
NO932044L
NO932044L NO93932044A NO932044A NO932044L NO 932044 L NO932044 L NO 932044L NO 93932044 A NO93932044 A NO 93932044A NO 932044 A NO932044 A NO 932044A NO 932044 L NO932044 L NO 932044L
Authority
NO
Norway
Prior art keywords
vinylazoles
vinylazole
functionalized
procedures
self
Prior art date
Application number
NO93932044A
Other languages
English (en)
Other versions
NO304428B1 (no
NO932044D0 (no
Inventor
Peter Strehlke
Rolf Bohlmann
Martin Schneider
Yukishige Nishino
Hans-Peter Muhnseipoldy
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO932044L publication Critical patent/NO932044L/no
Publication of NO932044D0 publication Critical patent/NO932044D0/no
Publication of NO304428B1 publication Critical patent/NO304428B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO932044A 1990-12-07 1993-06-04 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler NO304428B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4039559A DE4039559A1 (de) 1990-12-07 1990-12-07 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
PCT/EP1991/002359 WO1992010482A1 (de) 1990-12-07 1991-12-09 Funktionalisierte vinylazole enthaltende pharmazeutische präparate, verwendung dieser vinylazole zur herstellung von arzneimitteln, vinylazole selbst sowie verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
NO932044L true NO932044L (no) 1993-06-04
NO932044D0 NO932044D0 (no) 1993-06-04
NO304428B1 NO304428B1 (no) 1998-12-14

Family

ID=6420083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932044A NO304428B1 (no) 1990-12-07 1993-06-04 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler

Country Status (17)

Country Link
US (1) US5344834A (no)
EP (1) EP0550697A1 (no)
JP (1) JPH06503818A (no)
KR (1) KR930703263A (no)
CN (1) CN1064863A (no)
AU (1) AU660296B2 (no)
CA (1) CA2097824C (no)
CS (1) CS369691A3 (no)
DE (1) DE4039559A1 (no)
FI (1) FI932572A0 (no)
HU (1) HUT64036A (no)
IE (1) IE914259A1 (no)
IL (1) IL100274A (no)
NO (1) NO304428B1 (no)
PT (1) PT99714B (no)
WO (1) WO1992010482A1 (no)
ZA (1) ZA919662B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
US20020086856A1 (en) 1998-03-18 2002-07-04 Alfred Schmidt Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
CN100358866C (zh) * 2004-04-08 2008-01-02 上海交通大学 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法
JP6470984B2 (ja) * 2015-01-27 2019-02-13 学校法人東日本学園 アロマターゼ阻害剤及びこれを含む医薬
CN105732977B (zh) * 2016-01-30 2018-03-02 宝鸡文理学院 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580535A (en) * 1976-08-27 1980-12-03 Ici Ltd Substituted ketones and their use as herbicides
EP0003884A3 (en) * 1978-02-23 1979-09-19 Imperial Chemical Industries Plc Alpha-beta unsaturated ketone derivatives useful as herbicides
DE2826760A1 (de) * 1978-06-19 1980-01-03 Hoechst Ag Derivate des 1,2,4-triazols
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds

Also Published As

Publication number Publication date
FI932572A7 (fi) 1993-06-04
CS369691A3 (en) 1992-06-17
CN1064863A (zh) 1992-09-30
EP0550697A1 (de) 1993-07-14
IL100274A (en) 1996-08-04
IE914259A1 (en) 1992-06-17
NO304428B1 (no) 1998-12-14
CA2097824C (en) 2003-04-08
AU9045491A (en) 1992-07-08
AU660296B2 (en) 1995-06-22
DE4039559A1 (de) 1992-06-11
PT99714B (pt) 1999-05-31
PT99714A (pt) 1992-10-30
US5344834A (en) 1994-09-06
JPH06503818A (ja) 1994-04-28
HUT64036A (en) 1993-11-29
HU9301657D0 (en) 1993-09-28
ZA919662B (en) 1992-09-30
FI932572A0 (fi) 1993-06-04
NO932044D0 (no) 1993-06-04
WO1992010482A1 (de) 1992-06-25
IL100274A0 (en) 1992-09-06
CA2097824A1 (en) 1992-06-08
KR930703263A (ko) 1993-11-29

Similar Documents

Publication Publication Date Title
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
EE200000320A (et) Uudsed ühendid
AU7820191A (en) New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
DK267489A (da) 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler
FI891021A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
AR002039A1 (es) Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación
DK160981C (da) Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
NO932044D0 (no) Funksjonaliserte, vinylazolholdige, farmasoeytiske preparater, anvendelse av disse vinylazoler for fremstilling av legemidler, vinylazoler i seg selv, saavel som fremgangsmaater for deres fremstilling
NO883465D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av 1-fenyl-3-(1-piperazinyl)-1h-indazoler, og anvendelse derav som medikamenter.
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
AU1373097A (en) New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
NO308362B1 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
NO895195D0 (no) Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter.
FI895982A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi
FI905191A7 (fi) Bensocykloalylaminopyridinaminer och motsvarande föreningar, förfarande och mellanprodukter för deras framställning och deras användning som läkemedel
HUP9801068A2 (hu) 1,2,3,4-Tetrahidro-2-naftil-amin-származékok, ezek előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyászati készítmények
IL145041A0 (en) Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
DE69815854D1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
FI841739A0 (fi) Heterocyklyllaogalkyl-penem- foereningar, dessa foereningar innehaollande farmaceutiska preparat och anvaendning av de sistnaemnda.
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
DK648389A (da) Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler
FI960740A0 (fi) Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi, niiden käyttö farmaseuttisten valmisteiden valmistukseen ja niitä sisältäviä lääkkeitä